HAO (Haoxi Health Technology Co., Ltd.) גידול ברווח למניה בשנה הנוכחית

The fierce battle for medical traffic in China creates risks, as confirmed by the annual change in earnings per share on the GURU.Markets chart, where the indicator value reaches 0.00. While revenue growth is driven by AI optimization and new B2B contracts, low entry barriers in the video marketing sector leave the defensive moat of Haoxi Health Technology (HAO) extremely vulnerable.

For an investor in Haoxi Health Technology (HAO), this indicator serves as a benchmark for the effectiveness of monetizing demand for digital healthcare marketing in Asia. The measured YoY EPS growth is calculated as the percentage deviation of current earnings per share from the value of the same period last year. This price action reflects the business's ability to convert the expansion of its clinic client base into actual revenue. A positive trend confirms the model's resilience to market shocks, while the stability of this metric indicates high fundamental quality in capital management.